Patrick Spencer, RN, OCN provides important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.
Mark Lazenby, PhD, APRN, FAPOS, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses psychosocial topics that concern APOS.
Yale-New Haven Hospital (YNHH) currently credentials more than 400 advanced practice nurses (APNs) who practice in a wide range of roles and geographic locations. The number of practitioners more than doubled in the past 3 years, and now more than 50 APNs are practicing in oncology in Smilow Cancer Hospital at YNHH and at community care centers.
Christian Capitini discusses the responses to immunotherapy.
Nurses can lead the healthcare team when it comes to managing immune-related GI toxicities.
Claire Friedman discusses the factors clinicians should consider when determining an immunotherapy treatment plan for older patients.
Shuo Ma, MD, PhD, assistant professor at Northwestern University in the Robert H. Lurie Comprehensive Cancer Center, discusses some of the side effects that come with new agents approved for the treatment of non-Hodgkin Lymphoma.
The stigma around palliative care is that it is only associated with end of life, and in some minds, giving up. But that isn't the case, as palliative care is a vital part of any critical care.
Ann Culkin, MD, discusses how to ease patient fears of cancer treatment-related side effects.
Gwen Wyatt, PhD, RN, Professor, College of Nursing, Michigan State University, discusses a study that looks at acupressure to aid in relieving persistent cancer-related fatigue in breast cancer survivors.
There are multiple factors in making "cold" breast cancer tumors "hot," meaning that they respond to chemotherapy, explained Hope S. Rugo, MD, FASCO, director of Breast Oncology and Clinical Trials Education at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
While the regimen was overall well tolerated, there are some adverse events for nurses to look out for.
Lung cancer remains the leading cause of cancer mortality, killing more Americans than breast, colon, and prostate cancer combined—and Kentucky is the epicenter of lung cancer in the United States.
Significant advances have been made in diagnosing and treating bladder cancer, allowing for improved patient outcomes.
Susan Moore on the Importance of Oral Oncolytic Patient Education
Radiation therapy is key in treating patients with small cell and non-small cell lung cancer, explained Terence T. Sio, MD, MS, radiation oncologist and assistant professor of radiation oncology at the Mayo Clinic.
Oncology nurses are key players in helping patients with cancer find clinical trials, explained Martha Raymond, founder and CEO of the Raymond Foundation.
Being recognized as a lung cancer advocate made me realize how important even the smallest role in this fight can be.
Palliative care can be beneficial to patients treated with hematopoietic stem cell transplantation.
Supplements are well-tolerated (and can be beneficial) to patients with advanced pancreatic cancer, according to a small study.
Kim Noonan, MS, RN, ANP, AOCN, chief nurse practitioner, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses the challenges of treating patients with multiple myeloma.
Linda Casey, BSN, OCN, a nurse at the John Theurer Cancer Center, discusses working with and treating patients who are diagnosed with blood cancer.
Beth Sandy discusses the use of anti-psychotoci agent, olanzapine, when managing chemotherapy-induced nausea and vomiting (CINV).
Nadine Barrett, Ph.D., director of the Office of Health Equity and Disparities at the Duke Cancer Institute, discusses the importance of creating meaningful community partnerships that can improve health outcomes.
Both par­ents and clinicians need more valid information to guide them on how to interact with a child during painful procedures related to cancer treatment.
The indication for the DigniCap Cooling System has been expanded by the FDA to include alopecia reduction across all solid tumors.
Ashley Dietrich was diagnosed with Hodgkin's Lymphoma while pregnant at 6 weeks. Ashley's son, Beckett Anthony, was born in 2011.
One expert discusses findings from the TAILORx study.
A guide for oncology nurses on navigating the ever-growing field of direct-to-consumer genetic testing.